BCL2L2 抗体
Our Local Distributor
北京 101111
Quick Overview for BCL2L2 抗体 (ABIN6654583)
抗原
See all BCL2L2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
纯化方法
- Purified
-
纯度
- Protein G affinity chromatography
-
免疫原
- Full-length recombinant human protein was used as the immunogen for this Bcl2L2 antibody.
-
亚型
- IgG1
-
-
-
-
应用备注
-
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Bcl2L2 antibody to be titered up or down for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1) -
限制
- 仅限研究用
-
-
-
缓冲液
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
储存液
- Azide free
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store the Bcl2L2 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- BCL2L2 (BCL2-Like 2 (BCL2L2))
-
别名
- Bcl2L2 / Bcl-W
-
背景
- Bcl2L2, also called BCLW, promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.
抗原
-